Discover everything you need to know about MDR and IVDR compliance timelines for 2025. This eBook provides actionable insights to help manufacturers stay compliant and maintain market access.
About this eBook
This eBook serves as a detailed roadmap for medical device and IVD manufacturers preparing for the pivotal compliance deadlines under MDR and IVDR in 2025. It highlights critical timelines, key regulatory requirements, and actionable strategies to navigate this evolving landscape.
Whether you are addressing quality management systems, notified body certification, or EUDAMED registration, this eBook equips you with the knowledge to succeed.
View our other resources and company news
Guide Practical Guide to Post-Market Surveillance (PMS) under EU MDR/IVDR
The EU’s new Product Liability Directive (2024/2853) changes who can be held liable and what damages can be claimed. From software and data loss to ...
Read More
Blog AI for Pharmaceutical SOPs: Transforming Quality Management and Compliance
Rephine helps pharmaceutical and biotech companies transition to digital QMS platforms like Veeva Vault, MasterControl, or TrackWise. From vendor-neutral selection to full GxP-compliant validation and ...
Read More
CAPA Strengthening CAPA & Exceptions Management
Learn how Rephine’s tailored GxP training helped a pharmaceutical manufacturer strengthen CAPA effectiveness, improve compliance, and boost team confidence.
Read More
Blog EU GMP Annex 1 vs FDA Aseptic Guide: Bridging Compliance
EU and U.S. regulators share the same sterility assurance goals, but their approaches differ. Learn how to align Annex 1 and FDA guidance to streamline ...
Read More
Blog GMP & GDP: Ensuring Quality in Drug Storage and Transport
Storage and transport aren’t just logistics — they’re critical GMP processes. Discover how USP helps pharma companies manage risk and maintain quality across global ...
Read More
Blog Blockchain for GMP Documentation: Hype or Future Reality?
Blockchain promises immutability, traceability, and transparency for GMP documentation. But is it a compliance game-changer — or just hype?
Read More
Guide Is Your Insurance Policy Ready for the New EU Product Liability Directive?
The EU’s new Product Liability Directive (2024/2853) changes who can be held liable and what damages can be claimed. From software and data loss to ...
Read More
Article 100% Drug Tariffs in the U.S. – Impact on Pharma Supply Chains & Compliance
The U.S. has announced sweeping 100% tariffs on patented medicines, disrupting pharma supply chains and market access. Discover what this means for manufacturers — and ...
Read More
Blog Data Governance & AI in Pharma | Ensuring Trust & Compliance
In an age where AI promises transformation across pharma, success hinges on one factor: data you can trust. Explore how rigorous governance, quality control, and ...
Read More
